| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |